Askel Healthcare
Askel rebuilds joint surfaces for pain-free movement. COPLA® is a biodegradable implant that creates a weight-adaptive microenvironment to prevent OA.
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 Valuation: €0.0 1001.6x EV/Revenue -9.7x EV/EBITDA | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
N/A | Support Program | ||
| Total Funding | 000k | ||
| EUR | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | 60 % | (38 %) | (80 %) | - | 50 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (7620 %) | (3088 %) | (10340 %) | (36300 %) | (69000 %) | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (8980 %) | (4813 %) | (12960 %) | (49700 %) | (85600 %) | - |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 1200 % | 113 % | 2000 % | - | - | - |
Source: Company filings or news article, Dealroom estimates
Related Content
Developer of a medical device designed for cartilage repair in load bearing joints. The company's device provides evidence-based solutions for cartilage repair and prevention of osteoarthritis in veterinary medicine, enabling doctors and hospitals to treat more patients at a lower cost, with fewer complications and to enable quick rehabilitation.
Keywords: Healthcare Devices, Services, Supplies, Cartilage Repair Technology, Medical Advice, Medical Devices Design, Medical Devices Platform, Medical Devices Tech, Regenerative Medicine.